Cancer News and Research

Latest Cancer News and Research

States use retiree health care, Medicaid cuts to stare down budget gaps

State budget cuts are targeting health care and retiree health care programs in states around the U.S. In Maryland, a "doomsday" budget scenario could reduce Medicaid spending by $101 million while advocates push for reinstatement of Medicaid dollars in Idaho and Arizona.

8 Mar 2012

Global health community marks passing of U.S. Rep. Donald Payne

Rep. Donald Payne (D-N.J.), the first African American elected to Congress from New Jersey, died of complications from colon cancer on Tuesday at age 77, VOA News reports.

8 Mar 2012

Appendix cancer different from colon cancer

Researchers at Wake Forest Baptist Medical Center have demonstrated that cancer of the appendix is different than colon cancer, a distinction that could lead to more effective treatments for both diseases.

8 Mar 2012

Texas plan to defund women's health program draws protest; Other abortion and contraception news

Texas' move and subsequently imminent loss of federal Medicaid money has sparked a protest. Lawmakers in New Hampshire and Minnesota are examining the federal contraception coverage requirement.

8 Mar 2012

Metformin drug appears to prevent growth of atherosclerosis in patients with HIV

Treatment with the common diabetes drug metformin appears to prevent progression of coronary atherosclerosis in patients infected with HIV.

8 Mar 2012

Study suggests how and why high fat diets are linked to colon cancer

Epidemiologists have long warned that, in addition to causing obesity, eating too much fat and sugar puts a person at greater risk for colon cancer. Now, researchers at Temple University have established a link that may explain why.

8 Mar 2012

New inexpensive medical sensor may simplify diagnosis of diseases

An inexpensive new medical sensor has the potential to simplify the diagnosis of diseases ranging from life-threatening immune deficiencies to the common cold, according to its inventors at the Stanford University School of Medicine.

8 Mar 2012

Women with breast pain do not gain benefit from imaging

Researchers from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) have found that women with breast pain who receive imaging (mammograms, MRIs or ultrasounds) as part of breast pain evaluation, undergo follow-up diagnostic testing, but do not gain benefit from these additional studies.

8 Mar 2012

Researchers identify key molecular player in mouse model of kidney disease

In findings that may lead to clinical trials of a promising new drug for kidney disease, researchers at Beth Israel Deaconess Medical Center (BIDMC) and their colleagues have identified a key molecular player and shown how a targeted experimental drug can reverse kidney damage in mouse models of diabetes, high blood pressure, genetic kidney disease, and other kidney injuries.

8 Mar 2012

Combining radiation therapy with ipilimumab shows promise against melanoma

Research published today in the New England Journal of Medicine by scientists at the Ludwig Institute for Cancer Research (LICR) and Memorial Sloan-Kettering Cancer Center (MSKCC) showed that combining targeted radiation therapy with immunotherapy (ipilimumab), fostered a strong immune response and a favorable clinical outcome in a patient with melanoma, the most dangerous form of skin cancer.

8 Mar 2012

First 'theranostic' agent for treatment of ALL

A team of researchers at Case Western Reserve University School of Medicine has developed the first "theranostic" agent for the treatment of acute lymphoblastic leukemia (ALL).

8 Mar 2012

Sosei initiates SO-1105 Phase I trial in oropharyngeal candidiasis

Sosei Group Corporation, the biopharmaceutical company, today announces that its wholly owned Japanese subsidiary, Sosei Co., Ltd., has initiated a Japanese Phase I trial for SO-1105 for the treatment of oropharyngeal candidiasis.

8 Mar 2012

Researchers make significant strides in the study of Intrahepatic Cholangiocarcinoma

Researchers at the University of Rochester Medical Center's James P. Wilmot Cancer Center have made significant strides in the study of a primary cancer of the liver- Intrahepatic Cholangiocarcinoma (IHCC), also called biliary tract cancer.

8 Mar 2012

Celldex fourth quarter net loss increases to $12.7 million

Celldex Therapeutics, Inc. today reported financial results for the fourth quarter and the year ended December 31, 2011.

8 Mar 2012

Transgenomic fourth quarter total revenue increases 68% to $8.6M

Transgenomic, Inc. today reported financial results for the year ended December 31, 2011 and provided a business update.

7 Mar 2012

NCGR to host eighth annual NMBIST symposium on March 22-23, 2012

The National Center for Genome Resources (NCGR) announced today that it will host the eighth annual New Mexico Bioinformatics, Science and Technology (NMBIST) symposium on March 22-23, 2012.

7 Mar 2012

Genesys BioLabs introduces PAULA's test for early lung cancer detection

Genesys BioLabs, a division of 20/20 GeneSystems, Inc. announces today the launch of PAULA's test, a blood test for the early detection of lung cancer, addressing the need for a widely useable early detection protocol for asymptomatic patients.

7 Mar 2012

Viewpoints: WSJ on Super Tuesday; Zeke Emanuel, NY Times on electronic health records; Iowa high-risk pool concerns

Mr. Santorum is also scoring on the stump with his warnings about the threat to freedom posed by ObamaCare. Especially if the economy improves, this will be a crucial issue for Republicans in November because it reflects the great American fault line over the role of government. Yet the issue has bedeviled Mr. Romney's because of his refusal to distance himself from RomneyCare in Massachusetts and to say more than his cursory line that he'll "repeal ObamaCare."

7 Mar 2012

Illumina launches new highly multiplexed cancer panel

Illumina today introduced the TruSeq Amplicon - Cancer Panel, a highly multiplexed panel that will allow researchers to accurately sequence hundreds of the most relevant cancer loci, even in difficult samples such as formalin-fixed, paraffin embedded (FFPE) tumor samples.

From Illumina, Inc. 7 Mar 2012

AMTR soon after failure of AEDs may reduce risk of seizures in epilepsy patients

Patients with epilepsy who underwent brain surgery soon after failing to respond to drug treatment, but who also continued to receive drug therapy, had a lower risk of seizures during the 2nd year of follow-up compared to patients who received drug treatment alone, according to a study in the March 7 issue of JAMA.

7 Mar 2012